Stockreport

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

Relay Therapeutics, Inc.  (RLAY) 
PDF CAMBRIDGE, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discove [Read more]